"GEMINI II"@en . . "clinical trial"@en . . . . . . . "NCT00783692" . . . . . "2012-03-01T00:00:00Z"^^ . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . "18"^^ . . . . "klinisch onderzoek"@nl . . . . . . . . . "1116"^^ . . . . . . . . . . . . . . "Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease"@en . . "2008-12-01T00:00:00Z"^^ . . . . . . "Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease"@en . . . "Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease"@en . "80"^^ . "A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease"@en . . .